CG
SPHS

Cutler Group’s Sophiris Bio, Inc. SPHS Stock Holding History

Cutler Group’s Portfolio SPHS Stock Details SPHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-6,000
Closed -$11K – 5137
2018
Q2 		$11K Buy
6,000
+4,000
+200% +$11.9K ﹤0.01% 2655
2018
Q1 		$1K Buy
+2,000
New +$4.33K ﹤0.01% 4323
2017
Q2 		– Sell
-600
Closed -$2K – 7741
2017
Q1 		$2K Sell
600
-2,200
-79% -$6.03K ﹤0.01% 5708
2016
Q4 		$4K Buy
+2,800
New +$7.93K ﹤0.01% 5236

Other funds holding SPHS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Cutler Group's SPHS Position: Q4 2019 in Review

Cutler Group sold out of Sophiris Bio, Inc. (SPHS) in Q4 2019, closing a stake of 600 shares.

Cutler Group first reported a position in SPHS in Q3 2016 and held it in 10 quarters. The position peaked at $11K in Q2 2018. 27 funds tracked by Wall St. Rank hold SPHS as of Q4 2019.

  • Cutler Group reported no remaining Sophiris Bio, Inc. position as of Q4 2019 after selling out during the quarter.
  • Cutler Group sold 600 Sophiris Bio, Inc. shares in Q4 2019.
  • Cutler Group first reported a position in Sophiris Bio, Inc. in Q3 2016 and held it in 10 quarters.
  • Cutler Group's Sophiris Bio, Inc. position peaked at $11K in Q2 2018.
  • 27 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q4 2019.

Based on Cutler Group's 13F filing for Q4 2019, filed 6 Feb 2020.